SCHEMBL975249

SCHEMBL975249

CCC(C)(CNc1ccccc1)O[SiH3]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.41
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.36
TSHR P16473 2/20 0.35
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP2D6 P10635 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
LMNA P02545 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GHSR Q92847 1/20 0.32
CYP3A4 P08684 2/20 0.32
ALOX15 P16050 1/20 0.32
ALOX12 P18054 1/20 0.32
MAPK1 P28482 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL978044 0.79 SIGMAR1 (0.41) SIGMAR1MAPTALDH1A1TSHRCYP1A2
SCHEMBL11041549 0.77 MAPT (0.44) SIGMAR1MAPTALDH1A1TSHRCYP1A2
SCHEMBL5401394 0.72 PRSS1 (0.46) MAPTALDH1A1LMNAHIF1AMEN1
SCHEMBL3732806 0.72 MAPT (0.48) SIGMAR1MAPTALDH1A1TSHRCYP1A2
Hydrochloric Acid SCHEMBL17710416 0.70 MAPT (0.46) SIGMAR1MAPTALDH1A1TSHRCYP1A2
SCHEMBL28998256 0.69 MAPT (0.41) SIGMAR1MAPTALDH1A1TSHRCYP1A2
SCHEMBL21379732 0.69 MAPT (0.41) SIGMAR1MAPTALDH1A1TSHRCYP2C19
SCHEMBL15114122 0.69 ALDH1A1 (0.46) SIGMAR1MAPTALDH1A1TSHRCYP1A2
SCHEMBL17700506 0.69 MAPT (0.42) SIGMAR1MAPTALDH1A1TSHRCYP1A2
SCHEMBL4264763 0.69 MAPT (0.47) SIGMAR1MAPTALDH1A1TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2289898-B1 Melamine-functional organosilicon compound and making method SHINETSU CHEMICAL CO (JP) 2017-05-03 EP disclosed
US-8263766-B2 Melamine-functional organosilicon compound and making method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-09-11 US disclosed
EP-2289898-A1 Melamine-Functional organosilicon compound and making method Shin-Etsu Chemical Co., Ltd. (JP) 2011-03-02 EP disclosed
US-20110003989-A1 MELAMINE-FUNCTIONAL ORGANOSILICON COMPOUND AND MAKING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003989-A1 MELAMINE-FUNCTIONAL ORGANOSILICON COMPOUND AND MAKING METHOD MEN1, MSH6, PRMT6 SIGMAR1 2547/4885MAPT 1317/4885ALDH1A1 3030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.